GFPrint™: a machine learning tool for transforming genetic data into clinical insights

The increasing availability of massive genetic sequencing data in the clinical setting has triggered the need for appropriate tools to help fully exploit the wealth of information these data possess. GFPrint™ is a proprietary streaming algorithm designed to meet that need. By extracting the most relevant functional features, GFPrint™ transforms high-dimensional, noisy genetic sequencing data…

Topazium Receives the 2023 Artificial Intelligence and Advanced Technologies Award from the Madrid City Council for HealthGuard™

Madrid, February 21, 2024. Topazium, a company specializing in the application of artificial intelligence in the field of biomedicine, has been awarded the 2023 Artificial Intelligence and Advanced Technologies Award by the Madrid City Council for HealthGuard™, a machine learning framework designed and developed by the company that utilizes the most advanced AI technologies to…

Revista Emprendedores has selected Topazium as one of the 50 most innovative Spanish start-ups of 2023

Revista Emprendedores have searched for the most innovative projects of 2023 in the Spanish market to produce the 8th Emprendedores List of innovative startups. Spanish, innovative and very young. We have passed through these three filters to the country’s leading companies to draw up what is already the 8th Entrepreneurs List of innovative startups. So…

NutriGuard™ selected finalist for the Best Health Data Driven Innovation Award at DES#2023

NutriGuard™, Topazium’s AI tool to harness the healthy benefits of food, has been selected as a finalist for the Awards category: BEST HEALTH DATA-DRIVEN INNOVATION at #DES2023*! NutriGuard™ purpose is to promote and preserve health by using deep learning techniques applied to different sources of information. On the one hand, it takes all available information about…

Artificial intelligence in drug discovery: combining clinical and genomic data from cancer patients to identify genetic biomarkers and potential novel targets

Drug discovery is a costly process affected by a high attrition rate. The huge investment from pharma industry in past years has generated a vast wealth of information in the field that constitutes a great opportunity if it is conveniently exploited. Topazium is a company fully committed to creating a new collective intelligence that enables…